Genomic Updates To Drug Labeling Could Boost Gene Testing
This article was originally published in The Gray Sheet
Executive Summary
FDA could use results from a new research collaboration with Medco to update existing drug labeling with genomic information
You may also be interested in...
Personalized Medicine Isn’t Paying The Bills Yet; More Science Needed
Though the promise of personalized medicine has been widely touted, firms focusing on targeted therapies and companion diagnostics are not getting much bang for their buck - yet
Medco Gets Personal: LabCorp Agreement Pairs Cancer Med With AmpliChip
The pharmacy benefit manager Medco is working with the Laboratory Corporation of America to develop data on a personalized medicine approach to the use of the breast cancer drug tamoxifen
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”